Vol 54, No 2 (2016)
Original paper
Published online: 2016-06-06

open access

Page views 2069
Article views/downloads 2193
Get Citation

Connect on Social Media

Connect on Social Media

The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn’s disease patients in relation to mucosal healing

Piotr Eder, Liliana Lykowska-Szuber, Katarzyna Iwanik, Iwona Krela-Kazmierczak, Kamila Stawczyk-Eder, Przemyslaw Majewski, Krzysztof Linke, Elaine W. Kay, Aldona Wozniak
Pubmed: 27270504
Folia Histochem Cytobiol 2016;54(2):75-80.


Introduction. Immune-mediated angiogenesis may play an important role in the pathogenesis of inflammatory lesions in Crohn’s disease (CD). The study aimed to assess the influence of anti-tumour necrosis factor (anti-TNF) therapy on the angiogenesis in relation to microscopic and endoscopic healing in CD patients.

Material and methods. Colonic tissue samples from 17 CD patients were taken during colonoscopy before and after anti-TNF therapy. Endoscopic and microscopic severities were estimated using validated scores. Immunohistochemical expression of CD31 and vascular endothelial growth factor (VEGF) were assessed in parallel.

Results. The expression of CD31 and VEGF decreased significantly after the anti-TNF therapy in parallel to endoscopic improvement; however, the microscopic activity did not change significantly. There was a correlation between the change in CD31 and VEGF expression (p = 0.01; r = 0.6), as well as endoscopic healing (p = 0.04; r = 0.4). CD31 immunoexpression correlated with the number of poly- and mononuclear cells in the infiltrates in the mucosal lamina propria before the therapy (p = 0.02; r = 0.5).

Conclusions. We suggest that modulation of vascular proliferation can be a novel option to increase the efficacy of biological therapy in CD. 

Article available in PDF format

View PDF Download PDF file